Journal article

Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

E Mariño, JL Richards, KH McLeod, D Stanley, YA Yap, J Knight, C McKenzie, J Kranich, AC Oliveira, FJ Rossello, B Krishnamurthy, CM Nefzger, L Macia, A Thorburn, AG Baxter, G Morahan, LH Wong, JM Polo, RJ Moore, TJ Lockett Show all

Nature Immunology | NATURE PUBLISHING GROUP | Published : 2017

Abstract

Gut dysbiosis might underlie the pathogenesis of type 1 diabetes. In mice of the non-obese diabetic (NOD) strain, we found that key features of disease correlated inversely with blood and fecal concentrations of the microbial metabolites acetate and butyrate. We therefore fed NOD mice specialized diets designed to release large amounts of acetate or butyrate after bacterial fermentation in the colon. Each diet provided a high degree of protection from diabetes, even when administered after breakdown of immunotolerance. Feeding mice a combined acetate- and butyrate-yielding diet provided complete protection, which suggested that acetate and butyrate might operate through distinct mechanisms. ..

View full abstract

Grants

Awarded by Diabetes Australia Research Trust


Funding Acknowledgements

We thank S. Akira (Osaka University) for Myd88-/- mice; D.R. Powell, S. Archer, Deltagen, B. Scherer, H. Thomas, G. Jhala, L. Mason, H.Y. Goh, M. Udugama, F. Lim, Y.A. Leong, C. Ang Kim Lian, C. McKenzie and Monash Animal Services for assistance; the NIH Tetramer Facility for the IGRP and BDC2.5 tetramers; and the Monash Histology Platform of Monash University. Supported by the Juvenile Diabetes Research Foundation (3-2013-94), the Diabetes Australia Research Trust (Y14M1-MARE), and the Australian National Health and Medical Research Council (program grant 1016953 and Australia Fellowship 606947).